Anti-FBN3 antibody (1311-1361 aa) (STJ196573)

SKU:
STJ196573

Current Stock:
Host: Rabbit
Applications: IHC/IF
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Fibrillin-3 (1311-1361 aa) is suitable for use in Immunohistochemistry and Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: IHC-P 1:50-200
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FBN3
Gene ID: 84467
Uniprot ID: FBN3_HUMAN
Immunogen Region: 1311-1361 aa
Specificity: This antibody detects endogenous levels of FBN3 at Human
Immunogen: Synthesized peptide derived from the human FBN3 at the amino acid range 1311-1361
Post Translational Modifications Probably forms intermolecular disulfide bonds either with other FBN3 molecules or with other components of the microfibrils.
Function Fibrillin-3: Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-containing microfibrils provide long-term force bearing structural support.
Protein Name Fibrillin-3 Cleaved Into - Fibrillin-3 C-Terminal Peptide
Database Links Reactome: R-HSA-1474228
Reactome: R-HSA-1566948
Reactome: R-HSA-2129379
Cellular Localisation Secreted
Extracellular Space
Extracellular Matrix
Alternative Antibody Names Anti-Fibrillin-3 Cleaved Into - Fibrillin-3 C-Terminal Peptide antibody
Anti-FBN3 antibody
Anti-KIAA1776 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance